Sadelain M, Boulad F, Galanello R, Giardina P, Locatelli F, Maggio A, Rivella S, Riviere I, Tisdale J. Therapeutic options for patients with severe beta-thalassemia: the need for globin gene therapy. Hum Gene Ther. 2007 Jan;18(1):1-9.
Gardenghi S, Marongiu MF, Ramos P, Guy E, Breda L, Chadburn A, Liu Y, Amariglio N, Rechavi G, Rachmilewitz EA, Breuer W, Cabantchik ZI, Wrighting DM, Andrews NC, de Sousa M, Giardina PJ, Grady RW, Rivella S. Ineffective erythropoiesis in b-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood. 2007 Jun 1;109(11):5027-35. Epub 2007 Feb 13.
Harmatz P, Grady RW, Dragsten P, Vichinsky E, Giardina P, et al. Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator. Br J Haematol. 2007 Aug;138(3):374-81.
Vogiatzi MG, Macklin EA, Fung EB, Vichinsky E, Olivieri N, Kwiatkowski J, Cohen A, Neufeld E, Giardina PJ for the Thalassemia Clinical Research Network: Prevalence of Fractures Among the Thalassemia Syndromes in North America. Bone, 2006, 38(4):571-575.
Cappellini MD, Cohen A, Piga A, et. al.: A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood, May 2006; 107: 3455-3462.
Breda L, Gardenghi S, Guy E, Rachmilewitz EA, Weizer-Stern O, Adamsky K, Amariglio N, Rechavi G, Giardina PJ, Grady RW, Rivella S. Exploring the Role of Hepcidin, an Antimicrobial and Iron Regulator Peptide, in Increased Iron Absorption in Beta-Thalassemia. Annals New York Academy of Science, 2005 Nov;1054:417-22.
Vogiatzi MG, Autio KA, Mait JE, Schneider R, Lesser M, and Giardina PJ: Low Bone Mineral Density in Adolescents with Thalassemia. Annals of the New York Academy of Science, 2005 Nov;1054:462-6.
Cunningham MJ, Macklin EA, Neufeld EJ and Cohen AR. Complications of b-thalassemia major in North America. Blood. Jul 1;104(1):34-39, 2004
Vogiatzi MG, Autio KA, Schneider R and Giardina PJ: Low Bone Mass in Prepubertal Children with Thalassemia Major: Insights into the Pathogenesis of Low Bone Mass in Thalassemia. Journal of Pediatric Endocrinology and Metabolism, 17(10):1415-21, 2004
Nisbet-Brown, E., Olivieri, N.F., Giardina, P.J., Grady, R.W., Neufeld, E.J., Sechaud, R., Krebs-Brown, A.J., Anderson, J.R., Alberti, D., Sizer, K.C., Nathan, D.G.: Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomized, double-blind, placebo-controlled, dose-escalation trial. Lancet, 361(9369):1597-602, 2003.
Vogiatzi, M.G., Autio, K., Schneider, R., Giardina, P.J.: Low Bone Mass in Prepubertal Children with Thalassemia Major: Insights in the Pathogenesis of Low Bone Mass in Thalassemia and Implications for Treatment. J Ped Endo and Metab, 2002
Vogiatzi, M.G., Auto, K., Schneider, R., Giardina, P.J.: Low Bone Mass in Prepubertal Children with Thalassemia Major: Insights in the Pathogenesis of Low Bone Mass in Thalassemia and Implications for Treatment. J Peds, 2002.
Giardina, P.J. and Grady, R.W.: Chelation Therapy in Beta Thalassemia: An Optimistic Update. Seminars in Hematology, 38(4):360-366, 2001.
Heath, J.A., Boehm, C., Beaverson, K., Cutting, G., Giardina, P.J.: A novel Bet-thalassemia Intermedia Phenotype Containing Nt494 129T>C and Nt494 132C>A Mutation in cis A Nt168C>T (beta(0) 39 Point) Mutation in Trans. Am J Hematol, 67(1):57-8, 2001.
Cunningham-Rundles, S., Giardina, P.J., Grady, R.W., Califano, C., McKenzie, P., DeSousa, M.: Effect of Transfusional Iron Overload on Immune Response. Journal of Infectious Disease, 182 Suppl. 1:S115-121, 2000.
Grady, R.W. and Giardina, P.J.: Iron chelation with oral deferipone in patients with thalassemia. N Eng J Med. 339(23):1712-1713, 1998.
Hayward, A., Ambruso, D., Battaglia, F., Donlon, T., Eddelman, K., Giller, R., Hobbins, J., Hsia, Y.E., Quinones, R., Shpall, E., Trachtenberg, E., Giardina, P.J.: Microchimerism and Tolerance following Intrauterine Transplantation and Transfusion for ***-Thalassemia-1. Fetal Diagn Ther 13:8-14, 1998.
Bush, S., Mandel, F.S. and Giardina, P.J.: Future Orientation and Life Expectations of Young Adults with Thalassemia Major. Ann NY Acad. Sci. 850:361-369, 1998.
Calleja, E., Shen, J.Y., Lesser, M., Grady, R.W., New, M.I. and Giardina, P.J.: Survival and Morbidity in Transfusion Dependent Thalassemia Patients on Subcutaneous Desferrioxamine Chelation: Nearly Two Decades of Experience. NY Acad. Sci. 850:469-470, 1998.
Boulad, F., Giardina, P.J., Gillio, A., Kernan, N., Small, T., Brochstein, J., Van Syckle, K., George, D., Szabolcs, P., O'Reilly, R.: Bone Marrow Transplantation for Homozygous Beta-Thalassemia-The Sloan-Kettering Cancer Center Experience. NY Acad. Sci. 850:469-470, 1998.
